{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T02:23:48Z","timestamp":1794968628307,"version":"4.9.1"},"reference-count":134,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.ijantimicag.2020.106054","type":"journal-article","created":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T13:07:57Z","timestamp":1591794477000},"page":"106054","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":577,"title":["Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0877-1275","authenticated-orcid":false,"given":"Atul","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swapnil","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manas Kanti","family":"Deb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Louis","family":"Marty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2020.106054_bib0001","series-title":"One health: the human\u2013animal\u2013environment interfaces in emerging infectious diseases: the concept and examples of a one health approach","first-page":"49","article-title":"The importance of understanding the human\u2013animal interface","author":"Reperant","year":"2013"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0002","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.1016\/j.vaccine.2017.04.082","article-title":"Osterhaus ADME. AIDS, avian flu, SARS, MERS, Ebola, Zika\u2026 what next?","volume":"35","author":"Reperant","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0003","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s12250-016-3756-y","article-title":"Virus like particle-based vaccines against emerging infectious disease viruses","volume":"31","author":"Liu","year":"2016","journal-title":"Virol Sin"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0004","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1021\/acs.est.0c01102","article-title":"An imperative need for research on the role of environmental factors in transmission of novel coronavirus (COVID-19)","volume":"54","author":"Qu","year":"2020","journal-title":"Environ Sci Technol"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0005","doi-asserted-by":"crossref","first-page":"7790","DOI":"10.1128\/JVI.01244-13","article-title":"Commentary: Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group","volume":"87","author":"De Groot","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0006","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.ajic.2015.11.018","volume":"44","author":"Weber","year":"2016","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0007","unstructured":"World Health Organization. SARS statistics. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. Geneva: WHO. Revised on 26 Sep 2003. Available at:https:\/\/www.who.int\/csr\/sars\/country\/table2004_04_21\/en\/ [accessed 13 April 2020]."},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0008","unstructured":"World Health Organization. Statistics on Middle East respiratory syndrome. Geneva: WHO. Published on Nov 2019. Available at:https:\/\/www.who.int\/emergencies\/mers-cov\/en\/ [accessed 13 April 2020]."},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0009","series-title":"Ebola situation report 21 October 2015","year":"2015"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0010","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrd.2015.37","article-title":"Coronaviruses \u2013 drug discovery and therapeutic options","volume":"15","author":"Zumla","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0011","first-page":"1","article-title":"COVID-19 overview of information available to support the development of medical countermeasures and interventions against COVID-19","author":"Denis","year":"2020","journal-title":"Transdisciplinary Insights \u2013 Living Papers"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0012","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3181\/0903-MR-94","article-title":"Coronavirus diversity, phylogeny and interspecies jumping","volume":"234","author":"Woo","year":"2009","journal-title":"Exp Biol Med"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0013","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/22221751.2020.1719902","article-title":"Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan","volume":"9","author":"Chan","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0014","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0140-6736(20)30185-9","article-title":"A novel coronavirus outbreak of global health concern","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0015","series-title":"Novel coronavirus (2019-nCoV) situation report 22","year":"2020"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0016","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","article-title":"Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2","volume":"5","author":"Gorbalenya","year":"2020","journal-title":"Nat Micro"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0017","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(20)30419-0","article-title":"A distinct name is needed for the new coronavirus","volume":"395","author":"Jiang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0018","series-title":"Coronavirus disease 2019 (COVID-19) situation report 51","year":"2020"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0019","series-title":"Coronavirus disease (COVID-19) pandemic","year":"2020"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0020","series-title":"Medical microbiology","first-page":"587","article-title":"Coronaviruses","author":"Peiris","year":"2012"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-2438-7_1","article-title":"Coronaviruses: an overview of their replication and pathogenesis","volume":"1282","author":"Fehr","year":"2015","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0022","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s12098-020-03263-6","article-title":"A review of coronavirus disease-2019 (COVID-19)","volume":"87","author":"Singhal","year":"2020","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0023","series-title":"Report of the WHO\u2013China joint mission on coronavirus disease 2019 (COVID-19). Published on 28 Feb 2020","year":"2020"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0024","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0025","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1056\/NEJMc2001468","article-title":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany","volume":"382","author":"Rothe","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0026","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","article-title":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","volume":"382","author":"Li","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0027","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/jmv.25689","article-title":"Updated understanding of the outbreak of 2019 novel coronavirus (2019\u2010nCoV) in Wuhan, China","volume":"92","author":"Wang","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0028","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1164\/rccm.2014P7","article-title":"Novel Wuhan (2019-nCoV) coronavirus","volume":"201","author":"Carlos","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102433","article-title":"The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak","volume":"109","author":"Rothan","year":"2020","journal-title":"J Autoimmun"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0030","series-title":"Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations: scientific brief, 27 March 2020","year":"2020"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0031","first-page":"1843","article-title":"Detection of SARS-CoV-2 in different types of clinical specimens","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0032","series-title":"Diagnosis and treatment of novel coronavirus infection (trial version 6)","year":"2020"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0033","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1148\/radiol.2020200236","article-title":"CT imaging of the 2019 novel coronavirus (2019-nCoV) pneumonia","volume":"295","author":"Lei","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0034","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S1473-3099(13)70204-4","article-title":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study","volume":"13","author":"Assiri","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0035","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1056\/NEJMc2001272","article-title":"Importation and human-to-human transmission of a novel coronavirus in Vietnam","volume":"382","author":"Phan","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0036","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5582\/bst.2020.01020","article-title":"Drug treatment options for the 2019-new coronavirus (2019-nCoV)","volume":"14","author":"Lu","year":"2020","journal-title":"Biosci Trends"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0037","doi-asserted-by":"crossref","first-page":"e13209","DOI":"10.1111\/eci.13209","article-title":"The novel Chinese coronavirus (2019\u2010nCoV) infections: challenges for fighting the storm","volume":"50","author":"Bassetti","year":"2020","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0038","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.watres.2009.02.002","article-title":"Survival of surrogate coronaviruses in water","volume":"43","author":"Casanova","year":"2009","journal-title":"Water Res"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0039","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/S0140-6736(03)13412-5","article-title":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study","volume":"361","author":"Peiris","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0040","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMoa032867","article-title":"Evidence of airborne transmission of the severe acute respiratory syndrome virus","volume":"350","author":"Yu","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0041","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0140-6736(20)30360-3","article-title":"Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0042","first-page":"11","article-title":"The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak \u2013 an update on the status","volume":"7","author":"Guo","year":"2020","journal-title":"Mil Med Res"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0043","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0140-6736(20)30920-X","article-title":"SARS-CoV-2 and viral sepsis: observations and hypotheses","volume":"395","author":"Li","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0044","series-title":"Features, evaluation and treatment coronavirus (COVID-19)","author":"Cascella","year":"2020"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105938","article-title":"New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?","volume":"55","author":"Devaux","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","author":"Gautret","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105932","article-title":"Chloroquine and hydroxychloroquine as available weapons to fight COVID-19","volume":"55","author":"Colson","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0048","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0140-6736(13)60024-0","article-title":"Malaria","volume":"383","author":"White","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0049","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1386-6532(00)00140-2","article-title":"The potential place of chloroquine in the treatment of HIV-1-infected patients","volume":"20","author":"Boelaert","year":"2001","journal-title":"J Clin Virol"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0050","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S1473-3099(03)00806-5","article-title":"Effects of chloroquine on viral infections: an old drug against today's diseases","volume":"3","author":"Savarino","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0051","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/nrneph.2011.150","article-title":"The role of antimalarial agents in the treatment of SLE and lupus nephritis","volume":"7","author":"Lee","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0052","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ijantimicag.2007.05.015","article-title":"Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century","volume":"30","author":"Rolain","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0053","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004502","article-title":"Coronavirus cell entry occurs through the endo-\/lysosomal pathway in a proteolysis-dependent manner","volume":"10","author":"Burkard","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0054","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1743-422X-2-69","article-title":"Chloroquine is a potent inhibitor of SARS coronavirus infection and spread","volume":"2","author":"Vincent","year":"2005","journal-title":"Virol J"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0055","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S2213-2600(20)30172-7","article-title":"Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base","volume":"8","author":"Taccone","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0056","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5582\/bst.2020.01047","article-title":"Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies","volume":"14","author":"Gao","year":"2020","journal-title":"Biosci Trends"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0057","first-page":"185","volume":"43","year":"2020","journal-title":"Chin J Tuberc Respir Dis"},{"issue":"20","key":"10.1016\/j.ijantimicag.2020.106054_bib0058","article-title":"Hydroxychloroquine prophylaxis for COVID-19 contacts in India","volume":"S1473-3099","author":"Rathi","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0059","year":"2020"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0060","year":"2020"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0061","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00134-020-06022-5","article-title":"Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19)","volume":"46","author":"Alhazzani","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0062","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/d41587-020-00003-1","article-title":"Coronavirus puts drug repurposing on the fast track","volume":"38","author":"Harrison","year":"2020","journal-title":"Nat Biotech"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0063","doi-asserted-by":"crossref","first-page":"94","DOI":"10.18535\/jmscr\/v8i4.18","article-title":"Relevance and role of hydroxychloroquine in prophylaxis and therapy of COVID-19","volume":"8","author":"Baidya","year":"2020","journal-title":"J Med Sci Clin Res"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0064","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1096\/fasebj.11.4.9068613","article-title":"Sialic acids as ligands in recognition phenomena","volume":"11","author":"Varki","year":"1997","journal-title":"FASEB J"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0066","first-page":"ciaa237","article-title":"In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","author":"Yao","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0067","doi-asserted-by":"crossref","first-page":"23138","DOI":"10.1038\/srep23138","article-title":"Influenza A viruses escape from MxA restriction at the expense of efficient nuclear vRNP import","volume":"6","author":"G\u00f6tz","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0068","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.antiviral.2013.06.002","article-title":"Nuclear localization of dengue virus (DENV) 1\u20134 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor ivermectin","volume":"99","author":"Tay","year":"2013","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0069","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1042\/BJ20120150","article-title":"Ivermectin is a specific inhibitor of importin \u03b1\/\u03b2-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus","volume":"443","author":"Wagstaff","year":"2012","journal-title":"Biochem J"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0070","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1177\/1087057110390360","article-title":"An AlphaScreen\u00ae-based assay for high-throughput screening for specific inhibitors of nuclear import","volume":"16","author":"Wagstaff","year":"2011","journal-title":"J Biomol Screen"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0071","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1515\/hsz-2015-0171","article-title":"The importin \u03b1\/\u03b2-specific inhibitor ivermectin affects HIF-dependent hypoxia response pathways","volume":"396","author":"Kosyna","year":"2015","journal-title":"Biol Chem"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0072","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1158\/1535-7163.MCT-15-0052","article-title":"Targeting the nuclear import receptor Kpn\u03b21 as an anticancer therapeutic","volume":"15","author":"van der Watt","year":"2016","journal-title":"Mol Can Ther"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0073","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104787","article-title":"The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro","volume":"178","author":"Caly","year":"2020","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0074","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.virusres.2005.05.007","article-title":"Nuclear\/nucleolar localization properties of C-terminal nucleocapsid protein of SARS coronavirus","volume":"114","author":"Timani","year":"2005","journal-title":"Virus Res"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0075","doi-asserted-by":"crossref","first-page":"9345","DOI":"10.1128\/JVI.75.19.9345-9356.2001","article-title":"Localization to the nucleolus is a common feature of coronavirus nucleoproteins, and the protein may disrupt host cell division","volume":"75","author":"Wurm","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0076","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1186\/1756-0500-4-446","article-title":"A putative diacidic motif in the SARS-CoV ORF6 protein influences its subcellular localization and suppression of expression of co-transfected expression constructs","volume":"4","author":"Gunalan","year":"2011","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0077","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.2174\/0929867327666200416131117","article-title":"SARS CoV-2: recent reports on antiviral therapies based on lopinavir\/ritonavir, darunavir\/umifenovir, hydroxychloroquine, remdesivir, favipiravir and other drugs for the treatment of the new coronavirus","volume":"27","author":"Costanzo","year":"2020","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0078","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1021\/acs.biochem.0c00160","article-title":"Why are lopinavir and ritonavir effective against the newly emerged coronavirus 2019? Atomistic insights into the inhibitory mechanisms","volume":"59","author":"Nutho","year":"2020","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0079","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/thorax.2003.012658","article-title":"Role of lopinavir\/ritonavir in the treatment of SARS: initial virological and clinical findings","volume":"59","author":"Chu","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0080","series-title":"There is currently no strong evidence for the efficiency of lopinavir\/ritonavir in treatment of COVID-19","author":"Dorward","year":"2020"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0081","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1001\/jama.290.13.1695","article-title":"Old drugs for a new bug","volume":"290","author":"Vastag","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0082","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1126\/science.1085658","article-title":"Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs","volume":"300","author":"Anand","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0083","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104786","article-title":"Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro","volume":"178","author":"Choy","year":"2020","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0084","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/d41573-020-00016-0","article-title":"Therapeutic options for the 2019 novel coronavirus (2019-nCoV)","volume":"19","author":"Li","year":"2020","journal-title":"Nat Rev Drug Dis"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0085","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir-ritonavir in adults hospitalized with severe COVID-19","volume":"382","author":"Cao","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0086","article-title":"An exploratory randomized controlled study on the efficacy and safety of lopinavir\/ritonavir or arbidol treating adult patients hospitalized with mild\/moderate COVID-19 (ELACOI)","author":"Li","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0087","first-page":"1","article-title":"COVID\u201019 in a designated infectious diseases hospital outside Hubei Province, China","volume":"0","author":"Cai","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0088","article-title":"Risk factors associated with clinical outcomes in 323 COVID-19 patients in Wuhan, China","author":"Hu","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0089","unstructured":"Johnson & Johnson. Lack of evidence to support use of darunavir-based treatments for SARS-CoV-2. 2020. Available at: https:\/\/www.jnj.com\/lack-of-evidence-to-support-darunavir-based-hiv-treatments-for-coronavirus [accessed 4 April 2020]."},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0090","doi-asserted-by":"crossref","first-page":"58","DOI":"10.5582\/ddt.2020.01012","article-title":"Discovering drugs to treat coronavirus disease 2019 (COVID-19)","volume":"14","author":"Dong","year":"2020","journal-title":"Drug Discov Ther"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0091","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-13940-6","article-title":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV","volume":"11","author":"Sheahan","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0092","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0093","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMoa2001191","article-title":"First case of 2019 novel coronavirus in the United States","volume":"382","author":"Holshue","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0094","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/nature25978","article-title":"Planning chemical syntheses with deep neural networks and symbolic AI","volume":"555","author":"Segler","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0095","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/S0140-6736(20)30304-4","article-title":"Baricitinib as potential treatment for 2019-nCoV acute respiratory disease","volume":"395","author":"Richardson","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0096","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.str.2015.12.015","article-title":"Family-wide structural analysis of human numb-associated protein kinases","volume":"24","author":"Sorrell","year":"2016","journal-title":"Structure"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0097","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0098","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S1473-3099(20)30132-8","article-title":"COVID-19: combining antiviral and anti-inflammatory treatments","volume":"20","author":"Stebbing","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0099","unstructured":"Guidelines for the prevention, diagnosis, and treatment of novel coronavirus-induced pneumonia. 5th ed. Available at:http:\/\/www.nhc.gov.cn\/yzygj\/s7653p\/202002\/d4b895337e19445f8d728fcaf1e3e13a\/files\/ab6bec7f93e64e7f998d802991203cd6.pdf[accessed 21 April 2020]."},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0100","doi-asserted-by":"crossref","first-page":"581","DOI":"10.3201\/eid1004.030458","article-title":"Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs","volume":"10","author":"Tan","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0101","doi-asserted-by":"crossref","first-page":"e343","DOI":"10.1371\/journal.pmed.0030343","article-title":"SARS: systematic review of treatment effects","volume":"3","author":"Stockman","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0102","unstructured":"Jianping J, Randomized, open, blank control study on the efficacy and safety of recombinant human interferon \u03b11\u03b2; in the treatment of patients with new type of coronavirus infection in Wuhan. Source- U.S. National Library of Medicine. Published on 03 March 2020. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04293887 [accessed 21 April 2020]."},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0103","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2174\/092986708784049658","article-title":"Arbidol: a broad-spectrum antiviral compound that blocks viral fusion","volume":"15","author":"Boriskin","year":"2008","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0104","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1016\/j.bmc.2005.11.033","article-title":"Synthesis and in vitro anti-hepatitis B virus activities of some ethyl 5-hydroxy-1H-indole-3-carboxylates","volume":"14","author":"Zhao","year":"2006","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0105","first-page":"147","article-title":"Management of corona virus disease-19 (COVID-19): the Zhejiang experience","volume":"49","author":"Xu","year":"2020","journal-title":"J Zhejiang Univ (Med Sci)"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0106","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jinf.2020.03.002","article-title":"Arbidol combined with LPV\/r versus LPV\/r alone against corona virus disease 2019: a retrospective cohort study","volume":"81","author":"Deng","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0107","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jinf.2020.03.060","article-title":"Arbidol monotherapy is superior to lopinavir\/ritonavir in treating COVID-19","volume":"81","author":"Zhu","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0108","first-page":"168","article-title":"Effectiveness of convalescent plasma therapy in severe COVID-19 patients","volume":"4","author":"Duan","year":"2020","journal-title":"Proc Nat Acad Sci"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0109","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s10096-004-1271-9","article-title":"Use of convalescent plasma therapy in SARS patients in Hong Kong","volume":"24","author":"Cheng","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0110","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3851\/IMP3243","article-title":"Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience","volume":"23","author":"Ko","year":"2018","journal-title":"Antivir Ther"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0111","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMc070359","article-title":"Treatment with convalescent plasma for influenza A (H5N1) infection","volume":"357","author":"Zhou","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0112","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/infdis\/jiu396","article-title":"The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis","volume":"211","author":"Mair-Jenkins","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0113","series-title":"Recommendations for investigational COVID-19 convalescent plasma","year":"2020"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0114","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1136\/bmj.m1090","article-title":"COVID-19: how doctors and healthcare systems are tackling coronavirus worldwide","volume":"368","author":"Tanne","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0115","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1001\/jama.2020.4783","article-title":"Treatment of 5 critically ill patients with COVID-19 with convalescent plasma","volume":"323","author":"Shen","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0116","unstructured":"Venkateswaran TV, Singh J, India to explore novel blood plasma therapy for COVID-19. New Delhi. Published on 10 April 2020. Available at: https:\/\/www.thehindubusinessline.com\/news\/science\/india-to-explore-novel-blood-plasma-therapy-for-covid-19\/article31311466.ece [accessed 22 April 2020]."},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0117","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1021\/acscentsci.0c00272","article-title":"Research and development on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases","volume":"6","author":"Liu","year":"2020","journal-title":"ACS Cent Sci"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0118","series-title":"Bacille Calmette-Gu\u00e9rin (BCG) vaccination and COVID-19","year":"2020"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0119","unstructured":"University of Oxford: a study of a candidate COVID-19 vaccine (COV001). Source- U.S. National Library of Medicine. Published on 27 March 2020. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04324606 [accessed 22 April 2020]"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0120","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/d41587-020-00005-z","article-title":"The pandemic pipeline","volume":"38","author":"Hodgson","year":"2020","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0121","unstructured":"Duddu P. Coronavirus treatment: vaccines\/drugs in the pipeline for COVID-19. Available at: https:\/\/www.clinicaltrialsarena.com\/analysis\/coronavirus-mers-cov-drugs\/. Published on 16 April 2020. [accessed 22 April 2020]."},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0123","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109652","article-title":"Unique synergistic antiviral effects of Shufeng Jiedu Capsule and oseltamivir in influenza A viral-induced acute exacerbation of chronic obstructive pulmonary disease","volume":"121","author":"Ji","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0124","series-title":"\u201cSolidarity\u201d clinical trial for COVID-19 treatments","year":"2020"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0125","first-page":"1","article-title":"Withanone and caffeic acid phenethyl ester are predicted to interact with main protease (Mpro) of SARS-CoV-2 and inhibit its activity","author":"Kumar","year":"2020","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0126","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2020.112274","article-title":"The impact of biosensing in a pandemic outbreak: COVID-19","volume":"163","author":"Morales-Narv\u00e1ez","year":"2020","journal-title":"Biosens Bioelectron"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0127","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/6152041","article-title":"Learning from large-scale wearable device data for predicting epidemics trend of COVID-19","volume":"2020","author":"Zhu","year":"2020","journal-title":"Discrete Dyn Nat Soc"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0128","doi-asserted-by":"crossref","first-page":"65579","DOI":"10.1039\/C6RA10942J","article-title":"Design of a fluorescence aptaswitch based on the aptamer modulated nano-surface impact on the fluorescence particles","volume":"6","author":"Sharma","year":"2016","journal-title":"RSC Adv"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.aca.2018.04.032","article-title":"Development of a portable and disposable NS1 based electrochemical immunosensor for early diagnosis of dengue virus","volume":"1026","author":"Nawaz","year":"2018","journal-title":"Anal Chim Acta"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0130","series-title":"Nanomaterials for air remediation","first-page":"61","article-title":"Nanobiosensors for virus detection in the environment","author":"Khan","year":"2020"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0131","doi-asserted-by":"crossref","first-page":"31103","DOI":"10.1038\/srep31103","article-title":"Fluorescence based aptasensors for the determination of hepatitis B virus antigen","volume":"6","author":"Huang","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0132","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.bios.2014.09.033","article-title":"Ultrasensitive detection of streptomycin using flow injection analysis-electrochemical quartz crystal nanobalance (FIA-EQCN) biosensor","volume":"67","author":"Mishra","year":"2015","journal-title":"Biosens Bioelectron"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0133","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.cca.2006.07.029","article-title":"An SPR immunosensor for human cardiac troponin T using specific binding avidin to biotin at carboxymethyldextran-modified gold chip","volume":"376","author":"Dutra","year":"2007","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0134","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ab.2016.09.006","article-title":"Colorimetric aptasensor for progesterone detection based on surfactant-induced aggregation of gold nanoparticles","volume":"514","author":"Du","year":"2016","journal-title":"Anal Biochem"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0135","doi-asserted-by":"crossref","first-page":"5268","DOI":"10.1021\/acsnano.0c02439","article-title":"Dual-functional plasmonic photothermal biosensors for highly accurate severe acute respiratory syndrome coronavirus 2 detection","volume":"14","author":"Qiu","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijantimicag.2020.106054_bib0136","doi-asserted-by":"crossref","first-page":"5135","DOI":"10.1021\/acsnano.0c02823","article-title":"Rapid detection of COVID-19 causative virus (SARS-CoV-2) in human nasopharyngeal swab specimens using field-effect transistor-based biosensor","volume":"14","author":"Seo","year":"2020","journal-title":"ACS Nano"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857920302247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857920302247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:37:33Z","timestamp":1760377053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857920302247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":134,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0924857920302247"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.106054","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.106054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106054"}}